Graphics Chip Titan Registers Insider Selling; Four Other Companies with Fresh Insider Buying

Board Member of Cross Country Healthcare Purchases Shares

One member of Cross Country Healthcare Inc. (NASDAQ:CCRN)’s board piled up some shares earlier this week. Thomas C. Dircks snatched up 10,000 shares on Wednesday at prices that fell between $10.71 and $10.77 per share. Following the recent purchase, Mr. Dircks currently holds an ownership stake of 95,264 shares.

The shares of the national leader in providing healthcare workforce solutions and staffing services are 29% in the red thus far in 2016. Cross Country Healthcare Inc. (NASDAQ:CCRN) recorded revenue from services of $199.44 million for the three months that ended June 30, up from $192.62 million posted a year ago. The increase was mainly attributable to higher revenue from the company’s Nurse and Allied Staffing business segment as a result of the Mediscan acquisition, as well as higher average bill rates. A total number of 14 asset manager from our system were invested in Cross Country Healthcare at the end of the first quarter, accumulating 7% of the company’s outstanding shares. Richard Driehaus’ Driehaus Capital cut its stake in Cross Country Healthcare Inc. (NASDAQ:CCRN) by 8% during the June quarter to around 267,000 shares.

Graphics Chip Titan’s Executive Offloads Shares after Q2 Report

NVIDIA Corporation (NASDAQ:NVDA) was one company that registered spur-of-the-moment insider selling earlier this week. Debora Shoquist, Executive Vice President of Operations, offloaded 35,476 shares on Monday at prices ranging from $62.93 to $63.19 per share. Ms. Shoquist currently owns 352,188 shares of NVIDIA following the recent sale.

The insider selling comes shortly after the graphics chip titan released stronger than anticipates financial results for the second quarter, reflecting success with the recently-introduced graphic cards. NVIDIA Corporation (NASDAQ:NVDA) has seen its market capitalization spike by 87% since the start of the year. Following the release of the second-quarter earnings report, analysts at RBC Capital Markets upgraded the chip maker to ‘Outperform’ from ‘Sector Perform’ and raised their price target on the stock to $72 from $47, saying that “the NVIDIA story has materially changed to a structural long driven by 1) deep learning, 2) automotive, and 3) virtual reality growth.” John Armitage’s Egerton Capital Limited owns 4.75 million shares of NVIDIA Corporation (NASDAQ:NVDA) as of the end of the June quarter.

Disclosure: None